Join Us for the Virtual 81st Scientific Sessions!

Last year, we proved that despite Covid-19, connection isn’t cancelled by hosting more than 12,500 participants from around the world for a virtual Scientific Sessions, highlighting key scientific advances and breakthrough research.

While we were hoping to see you all in person this June, the health and safety of our attendees, staff and exhibitors remains the top priority of the American Diabetes Association® (ADA)—which is why we have made the decision to transition the 2021 Scientific Sessions to a virtual meeting, June 25-29, 2021. Attendees will receive exclusive access to all virtual content for 90-days after the event, with access ending September 29, 2021.

You can rest assured that the virtual 81st Scientific Sessions will continue to offer the latest groundbreaking science that you have come to expect from the ADA—so that, together, we can continue to help the 460 million people worldwide living with diabetes thrive.

Diabetes Technology & Therapeutics is the only peer-reviewed journal providing healthcare professionals with information on new devices, drugs, drug delivery systems, and software for managing patients with diabetes. This leading international journal delivers practical information and comprehensive coverage of cutting-edge technologies and therapeutics in the field, and each issue highlights new pharmacological and device developments to optimize patient care.

Check out the virtual event at the ADA Scientific Sessions